BLACK DIAMOND THERAPEUTICS I shareholders Q2 2023

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 75 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

BLACK DIAMOND THERAPEUTICS I shareholders Q2 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 800,000$4,040,0004.89%
CVI Holdings, LLC 750,000$3,787,5003.98%
NEA Management Company, LLC 4,448,757$22,466,2231.72%
CHI Advisors LLC 750,000$3,787,5001.15%
Bellevue Group AG 8,135,839$41,085,9870.59%
Boxer Capital, LLC 2,014,858$10,1750.47%
Ikarian Capital, LLC 545,103$2,752,7700.44%
Parkman Healthcare Partners LLC 500,000$2,525,0000.44%
RA Capital Management 3,525,754$17,805,0580.34%
Opaleye Management Inc. 275,000$1,388,7500.33%
Artal Group S.A. 2,046,517$10,3350.32%
VR Adviser, LLC 353,629$1,785,8260.29%
Soleus Capital Management, L.P. 435,000$2,196,7500.24%
Newtyn Management, LLC 200,000$1,010,0000.24%
Monashee Investment Management LLC 170,000$858,5000.20%
EAM Investors, LLC 207,428$1,047,5110.19%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,800,000$9,090,0000.19%
Eversept Partners, LP 427,317$2,157,9510.18%
RTW INVESTMENTS, LP 1,700,000$8,585,0000.16%
KENNEDY CAPITAL MANAGEMENT LLC 751,403$3,794,5850.09%
External links

This page lists BLACK DIAMOND THERAPEUTICS I's shareholders in Q2 2023. To view BLACK DIAMOND THERAPEUTICS I's shareholder history, click here.